If You’re A Risk-Taking Investor, Checkpoint Therapeutics Inc (NASDAQ: CKPT) Is Worth Taking A Chance On.
In today’s recent session, 3.46 million shares of the Checkpoint Therapeutics Inc (NASDAQ:CKPT) have been traded, and its beta is 1.13. Most recently the company’s